National Comprehensive Cancer Network

|
|
|
|
For Patients
About the NCCN Clinical Practice Guidelines in Oncology™
Recent Updates to NCCN Clinical Practice Guidelines in Oncology™
NCCN Categories of Evidence and Consensus
NCCN Guidelines Steering Committee
Submission Request to the NCCN Guidelines Panels
NCCN Guidelines Panels-Meeting Schedule
NCCN Drugs & Biologics Compendium™
About the NCCN Drugs & Biologics Compendium™
Compendium Chapters
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

Clinical Recommendations

NCCN Drug and Biologics Compendium - Panel Members

Professionals


Go back to previous page

 

 

   
 

NCCN Drugs & Biologics Compendium

NCCN Anal Carcinoma Panel Members

These chapters of the NCCN Drugs & Biologics Compendium™ were developed directly from the NCCN Clinical Practice Guidelines in Oncology for Anal Carcinoma.

These guidelines were developed by the following NCCN Anal Carcinoma Panel Members.

Paul F. Engstrom, MD/Chair
Fox Chase Cancer Center
Anal Carcinoma

Juan Pablo Arnoletti, MD
University of Alabama at Birmingham Comprehensive Cancer Center
Anal Carcinoma

Al B. Benson, III, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Anal Carcinoma

Jordan D. Berlin, MD
Vanderbilt-Ingram Cancer Center
Anal Carcinoma

J. Michael Berry, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Anal Carcinoma

Yi-Jen Chen, MD, PhD
City of Hope Comprehensive Cancer Center
Anal Carcinoma

Michael A. Choti, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Anal Carcinoma

Harry S. Cooper, MD
Fox Chase Cancer Center
Anal Carcinoma

Raza A. Dilawari, MD
St. Jude Children's Research Hospital/University of Tennessee Cancer Institute
Anal Carcinoma

Dayna S. Early, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Anal Carcinoma

Peter C. Enzinger, MD
Dana-Farber/Brigham and Women's Cancer Center
Anal Carcinoma

Marwan G. Fakih, MD
Roswell Park Cancer Institute
Anal Carcinoma

James Fleshman, Jr., MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Anal Carcinoma

Charles Fuchs, MD
Dana-Farber/Brigham and Women's Cancer Center
Anal Carcinoma

Jean L. Grem, MD
UNMC Eppley Cancer Center at The Nebraska Medical Center
Anal Carcinoma

James A. Knol, MD
University of Michigan Comprehensive Cancer Center
Anal Carcinoma

Lucille A. Leong, MD
City of Hope Comprehensive Cancer Center
Anal Carcinoma

Edward Lin, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Anal Carcinoma

Mary F. Mulcahy, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Anal Carcinoma

Eric Rohren, MD, PhD
The University of Texas M. D. Anderson Cancer Center
Anal Carcinoma

David P. Ryan, MD
Massachusetts General Hospital Cancer Center
Anal Carcinoma

Leonard Saltz, MD
Memorial Sloan-Kettering Cancer Center
Anal Carcinoma

David Shibata, MD
H. Lee Moffitt Cancer Center & Research Institute
Anal Carcinoma

John M. Skibber, MD
The University of Texas M. D. Anderson Cancer Center
Anal Carcinoma

Willliam Small, Jr., MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Anal Carcinoma

Constantinos Sofocleous, MD, PhD
Memorial Sloan-Kettering Cancer Center
Anal Carcinoma

James Thomas, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute
Anal Carcinoma

Alan P. Venook, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Anal Carcinoma

Christopher Willett, MD
Duke Comprehensive Cancer Center
Anal Carcinoma

 
 
 

Disclosures for the NCCN Anal Carcinoma Guidelines Panel